BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38009865)

  • 21. Translating morphology from bench side to bed side via neurophysiology: 8-min protocol for peripheral neuropathy research.
    Monza L; Fumagalli G; Chiorazzi A; Alberti P
    J Neurosci Methods; 2021 Nov; 363():109323. PubMed ID: 34391792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of peripheral neuropathy induced by platinum in first-line chemotherapy on second-line chemotherapy with paclitaxel for advanced gastric cancer.
    Otsuka R; Iwasa S; Yanai T; Hirano H; Shoji H; Honma Y; Okita N; Takashima A; Kato K; Hashimoto H; Sekiguchi M; Makino Y; Boku N; Yamaguchi M
    Int J Clin Oncol; 2020 Apr; 25(4):595-601. PubMed ID: 31853798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin.
    McHugh JC; Tryfonopoulos D; Fennelly D; Crown J; Connolly S
    Eur J Cancer Care (Engl); 2012 Nov; 21(6):782-9. PubMed ID: 22594346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity.
    Park SB; Goldstein D; Lin CS; Krishnan AV; Friedlander ML; Kiernan MC
    J Clin Oncol; 2009 Mar; 27(8):1243-9. PubMed ID: 19164207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ion Channel and Transporter Involvement in Chemotherapy-Induced Peripheral Neurotoxicity.
    Pozzi E; Terribile G; Cherchi L; Di Girolamo S; Sancini G; Alberti P
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity.
    Pozzi E; Fumagalli G; Chiorazzi A; Canta A; Meregalli C; Monza L; Carozzi VA; Oggioni N; Rodriguez-Menendez V; Cavaletti G; Marmiroli P
    Exp Neurol; 2020 Dec; 334():113458. PubMed ID: 32889007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy.
    Pozzi E; Monza L; Ballarini E; Bossi M; Rodriguez-Menendez V; Canta A; Chiorazzi A; Carozzi VA; Crippa L; Marmiroli P; Cavaletti G; Alberti P
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Axonal Excitability Does Not Differ between Painful and Painless Diabetic or Chemotherapy-Induced Distal Symmetrical Polyneuropathy in a Multicenter Observational Study.
    Themistocleous AC; Kristensen AG; Sola R; Gylfadottir SS; Bennedsgaard K; Itani M; Krøigård T; Ventzel L; Sindrup SH; Jensen TS; Bostock H; Serra J; Finnerup NB; Tankisi H; Bennett DLH
    Ann Neurol; 2022 Apr; 91(4):506-520. PubMed ID: 35150149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurofilament proteins as a potential biomarker in chemotherapy-induced polyneuropathy.
    Huehnchen P; Schinke C; Bangemann N; Dordevic AD; Kern J; Maierhof SK; Hew L; Nolte L; Körtvelyessy P; Göpfert JC; Ruprecht K; Somps CJ; Blohmer JU; Sehouli J; Endres M; Boehmerle W
    JCI Insight; 2022 Mar; 7(6):. PubMed ID: 35133982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protease-Activated Receptor 2 (PAR2) Expressed in Sensory Neurons Contributes to Signs of Pain and Neuropathy in Paclitaxel Treated Mice.
    Kume M; Ahmad A; DeFea KA; Vagner J; Dussor G; Boitano S; Price TJ
    J Pain; 2023 Nov; 24(11):1980-1993. PubMed ID: 37315729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxaliplatin treatment and peripheral nerve damage in cancer patients: A Polish cohort study.
    Banach M; Zygulska AL; Krzemieniecki K
    J Cancer Res Ther; 2018; 14(5):1010-1013. PubMed ID: 30197340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of non-macrophage cell-derived HMGB1 in oxaliplatin-induced peripheral neuropathy and its prevention by the thrombin/thrombomodulin system in rodents: negative impact of anticoagulants.
    Tsubota M; Fukuda R; Hayashi Y; Miyazaki T; Ueda S; Yamashita R; Koike N; Sekiguchi F; Wake H; Wakatsuki S; Ujiie Y; Araki T; Nishibori M; Kawabata A
    J Neuroinflammation; 2019 Oct; 16(1):199. PubMed ID: 31666085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity.
    Canta A; Chiorazzi A; Pozzi E; Fumagalli G; Monza L; Meregalli C; Carozzi VA; Rodriguez-Menendez V; Oggioni N; Näsström J; Marmiroli P; Cavaletti G
    Antioxidants (Basel); 2020 Jul; 9(7):. PubMed ID: 32645985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy.
    Melli G; Taiana M; Camozzi F; Triolo D; Podini P; Quattrini A; Taroni F; Lauria G
    Exp Neurol; 2008 Dec; 214(2):276-84. PubMed ID: 18809400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vinca alkaloids, thalidomide and eribulin-induced peripheral neurotoxicity: From pathogenesis to treatment.
    Islam B; Lustberg M; Staff NP; Kolb N; Alberti P; Argyriou AA
    J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2():S63-S73. PubMed ID: 31647152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative assessment of chemotherapy-induced peripheral neurotoxicity using a point-of-care nerve conduction device.
    Matsuoka A; Mitsuma A; Maeda O; Kajiyama H; Kiyoi H; Kodera Y; Nagino M; Goto H; Ando Y
    Cancer Sci; 2016 Oct; 107(10):1453-1457. PubMed ID: 27412083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methods for in vivo studies in rodents of chemotherapy induced peripheral neuropathy.
    Bruna J; Alberti P; Calls-Cobos A; Caillaud M; Damaj MI; Navarro X
    Exp Neurol; 2020 Mar; 325():113154. PubMed ID: 31837318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy-induced peripheral neuropathy-patient-reported outcomes compared with NCI-CTCAE grade.
    Tan AC; McCrary JM; Park SB; Trinh T; Goldstein D
    Support Care Cancer; 2019 Dec; 27(12):4771-4777. PubMed ID: 30972648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy and safety of pregabalin for oxaliplatin- and paclitaxel-induced peripheral neuropathy].
    Nihei S; Sato J; Kashiwaba M; Itabashi T; Kudo K; Takahashi K
    Gan To Kagaku Ryoho; 2013 Sep; 40(9):1189-93. PubMed ID: 24047777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrophysiological and phenotypic profiles of taxane-induced neuropathy.
    Timmins HC; Li T; Huynh W; Kiernan MC; Baron-Hay S; Boyle F; Goldstein D; Park SB
    Clin Neurophysiol; 2020 Aug; 131(8):1979-1985. PubMed ID: 32291143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.